1. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach,2013
2. Haas D, Hicks C, Seekins D, et al. A phase 2, double-blind, placebo-controlled, dose-ranging study to assess the antiretroviral activity and safety of efavirenz (DMP 266) in combination with open-label zidovudine and lamivudine at 24 weeks (DMP 005). Fifth Conference on Retroviruses and Opportunistic Infections; Chicago, IL, USA; Feb 1–5, 1998. Abstract 698.
3. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial;Lancet,2014
4. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity;Ware;Med Care,1996
5. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample;Henry;Br J Clin Psychol,2005